All Type of News
“National Health Insurance’s KRW 20 trillion surpluses should be used to strengthen coverages”
Should the KRW 20 trillion surpluses accumulated in the National Health Insurance budget be used to strengthen insurance coverages? Or should they be invested to solve the chronically low insurance prices?
As the sur...
MOHW, “Propriety of insurance prices will be reviewed in first half of 2017”
The Ministry of Health and Welfare(MOHW) will conduct studies and reviews about propriety of drug insurance prices in Korea next year.
As an answer to the question raised at the recent National Assembly, the MOHW del...
Multinational pharmas to make active moves for sales
Multinational pharmaceutical companies have conducted various events to promote their OTC drug sales.
In order to celebrate the 1st anniversary of ‘Actinum EX Plus,’ Takeda Pharmaceuticals Korea recently held the ‘2...
What is reason for low immunization rate on cervical cancer vaccines?
The participation rate of the National Immunization Program for cervical cancer vaccines, which was implemented last June, is observed to be low.
According to the Ministry of Health and Welfare(MOHW) on the 25th, th...
Development of oral RA treatments, heated by Korean companies’ patent suits
Development of the Pfizer Pharmaceuticals Korea’s oral rheumatoid arthritis(RA) treatment Xeljanz(generic name: tofacitinib) has been heated.
According to the Intellectual Property Tribunal, the total 12 pharmaceutic...
President Park, “The government plans to focus on supporting R&D of biomedicines”
President Geun-Hye Park announced R&D support plans focusing on biomedicines.
At the ‘Next Year’s Budget Speech’ on the 24th, President Park explained the 2017’s budget which exceeds KRW 40 trillion, and stressed the...
Rebate investigation on foreign & Korean pharmas
It was told the police is currently carrying out rebate investigation on about 10 multinational and Korean pharmaceutical companies.
Since some of them are powerful pharmaceutical companies, significant impacts are e...
Why Sanofi’s labor union demand reinstatement of two employees violating CP?
Last March, Sanofi-Aventis Korea dismissed its two salespersons, who use corporate expenses without permission, for violation of the Compliance Program(CP).
Later, the company’s labor union has continued a protest to...
MFDS largely expand the number of personnel for drug approval and assessment
The Ministry of Food and Drug Safety(MFDS) will expand the number of personnel for approval and assessment.
The MFDS administrative notified the ‘Partial Revision to the Fee Policy Related to Drug Approval,’ which in...
Hanmi acquires approval of combined treatment for ‘prostatic hypertrophy and erectile dysfunction’
On the 21st, Hanmi Pharm(CEO Gwan-Sun Lee) announced approval to commercialize ‘Gugutams Cap(generic name: tamsulosin 0.4mg+tadalafil 5mg)’ that combines substances for benign prostatic hypertrophy and erectile dysfun...
